Douglas W. Axelrod, M.D., Ph.D., has been appointed senior vice president for clinical R&D, Ambrx, Inc.     Dr. Axelrod joins the company after a 20-year career at Procter & Gamble Pharmaceuticals. Most recently, he served as vice president of R&D for Discovery, Early Development and Product Development where he accelerated the discovery process, improved the discovery to early development transition and led efficiencies in product development. Dr. Axelrod also led the P&G Wor...